MHRA Drug Safety Update: December 2023

A new Medicines and Healthcare products Regulatory Agency (MHRA) Drug Safety Update (Vol 17 Issue 5 December 2023) has been published and includes articles on:

  • Aripiprazole (Abilify and generic brands): risk of pathological gambling
  • Vitamin B12 (hydroxocobalamin, cyanocobalamin): advise patients with known cobalt allergy to be vigilant for sensitivity reactions
  • Letters and medicine recalls sent to healthcare professionals in November 2023.

To see the latest MHRA Drug Safety Updates in full, visit the website.